Publication | Open Access

Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirologyVaccine DesignMedicineVaccine Research